451
Participants
Start Date
January 31, 2006
Primary Completion Date
November 30, 2006
Study Completion Date
November 30, 2006
Dexlansoprazole MR
Dexlansoprazole MR 60 mg, capsules, orally, once daily for up to six months.
Dexlansoprazole MR
Dexlansoprazole MR 90 mg, capsules, orally, once daily for up to six months.
Placebo
Dexlansoprazole placebo-matching capsules, orally, once daily for up to six months.
Alabaster
Birmingham
Huntsville
Phoenix
Scottsdale
Tucson
Anaheim
Chula Vista
Fullerton
Garden Grove
Irvine
Lancaster
Long Beach
Los Angeles
Mission Hills
Palm Springs
Redwood City
San Diego
San Luis Obispo
Boulder
Colorado Springs
Lone Tree
Wheat Ridge
Waterbury
Boynton Beach
Jacksonville
Jupiter
Kissimmee
Lakeland
New Port Richey
Atlanta
Honolulu
Arlington Heights
Chicago
Hines
Oak Park
Rockford
Clive
Dubuque
Newton
Shawnee Mission
Topeka
Metairie
Shreveport
Hollywood
Lutherville
Troy
Chaska
Jackson
Mexico
St Louis
Washington
Omaha
Pahrump
New Brunswick
Bingampton
Brooklyn
Great Neck
Rochester
Charlotte
Elkin
Greensboro
Hickory
Salisbury
Statesville
Winston-Salem
Cincinnati
Mayfield Heights
Warren
Oklahoma City
Portland
Beaver Falls
Duncansville
Lansdale
Bristol
Chattanooga
Hermitage
Nashville
Austin
Beaumont
Bedford
Bryan
Corsicana
El Paso
Fort Worth
Houston
San Antonio
Bountiful
Ogden
Salt Lake City
West Jordan
Chesapeake
Danville
Spokane
Milwaukee
Monroe
Lead Sponsor
Takeda
INDUSTRY